Greet Claessens

Tumour necrosis factor‐α receptor 1 and 2 polymorphisms in inflammatory bowel disease and their association with response to infliximab

Séverine Vermeire, Kristel Van Steen, Sofie Joossens et al. · Alimentary Pharmacology & Therapeutics · 2004 · 150 citations · Full text

Life Sciences, Immunology, Molecular Genetics +15

Pancreatic Autoantibodies in Inflammatory Bowel Disease

Sofie Joossens, Séverine Vermeire, Kristel Van Steen et al. · Inflammatory Bowel Diseases · 2004 · 72 citations · Full text

Life Sciences, Immunology, Internal Medicine +17

Transmission of CARD15 (NOD2) Variants Within Families of Patients with Inflammatory Bowel Disease

Nele Esters, Kristel Van Steen, Séverine Vermeire et al. · The American Journal of Gastroenterology · 2004 · 66 citations

Life Sciences, Genetics, Molecular Genetics +17

Interassay and Interobserver Variability in the Detection of Anti-neutrophil Cytoplasmic Antibodies in Patients with Ulcerative Colitis

Sofie Joossens, Marco Daperno, Zakera Shums et al. · Clinical Chemistry · 2004 · 35 citations

Life Sciences, Immunology, Pathology +17

Role of ASCA and the NOD2/CARD15 mutation Gly908Arg in predicting increased surgical costs in Crohnʼs disease patients: A project of the European Collaborative Study Group on Inflammatory Bowel Disease

Shmuel Odes, Michael Friger, Hillel Vardi et al. · Inflammatory Bowel Diseases · 2007 · 27 citations

Medicine, Immunology, Molecular Genetics +17